HST Global to Offer Free Samples of FocusUP

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC) today announced that it is offering free samples of FocusUP®, its new cognitive function product endorsed and recommended by Dr. Kyl Smith.

“With the impending launch of the FocusUP® campaign, we recognize the importance of establishing brand name recognition and wide scale market exposure. As a result, we are offering free samples of FocusUP® to the first 1,000 individuals that e-mail the company requesting our new product.”

Ron Howell, CEO/President stated, “With the impending launch of the FocusUP® campaign, we recognize the importance of establishing brand name recognition and wide scale market exposure. As a result, we are offering free samples of FocusUP® to the first 1,000 individuals that e-mail the company requesting our new product.”

To request free samples of FocusUP®, please e-mail the company at freeoffer@hstglobal.com and provide the following:

Name

Address

City, State, Zip Code

Phone Number

E-mail Address

About HST Global, Inc.

HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on immunotherapy and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.

HST Global, Inc. wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.